THE DATA ADVANTAGE
Longitudinal cancer biology, observed in the real world.
Human oncology remains the destination. Naturally occurring canine cancer provides an additional source of real-world molecular, treatment, and outcome data that can help reveal conserved biological patterns.
Why this data is different
Spontaneous disease
Tumors arise naturally rather than through artificial experimental induction.
Intact biological systems
Disease evolves within an intact immune system and complex tumor microenvironment.
Real treatment trajectories
Clinical care creates observable treatment, progression, recurrence, and survival histories.
Compressed timelines
Cancer trajectories can mature faster, creating earlier access to longitudinal outcome signal.
Every cross-species insight must return to human biology.
Clyra does not treat canine data as a replacement for human evidence. The platform uses it as complementary information: a second biological view that may strengthen subgroup discovery, expose conserved tumor states, and prioritize hypotheses for validation in human datasets.
Designed for translational rigor
Species-aware biological alignment
Cohort and modality harmonization
Separation of conserved signal from species-specific variation
Human-centered validation of translational hypotheses